What Researchers Did
Researchers conducted a preliminary clinical study on 16 multiple sclerosis patients, treating them with 25-30 hyperbaric oxygen exposures at 2 ata.
What They Found
Of the 16 patients, 14 showed significant improvement, while one patient experienced worsening after 15 exposures. Immunological analysis revealed a general decrease in serum IgG, IgM, and IgA, alongside an increase in complement activity.
What This Means for Canadian Patients
This early research suggests hyperbaric oxygen therapy might offer some benefit for multiple sclerosis symptoms. However, more robust and modern studies are needed to confirm these findings and determine its safety and efficacy for Canadian patients.
Canadian Relevance
This study has no direct Canadian connection.
Study Limitations
Key limitations include the small sample size of 16 patients and the preliminary nature of the findings.